Science in Seattle

Expanding Minds - The Allen Institute Conference on Human Brain Evolution
2021-01-26 08:00 - 17:00 (America/Vancouver) | Online
The Allen Institute is pleased to host a reimagined, virtual Expanding Minds – The Allen Institute Conference on Human Brain Evolution. This meeting will feature the latest insights in human brain evolution, chaired by Chris Walsh, M.D., Ph.D., Michael Greenberg, Ph.D., and David Reich, Ph.D., of the Allen Discovery Center for Human Brain Evolution.
The symposium was previously scheduled for April 1-2, 2020 at the Allen Institute in Seattle, WA. In order to accommodate the full lineup of speakers in a virtual format, the symposium will now be presented as a series of virtual events. The kickoff event will be hosted by the Allen Institute as a Zoom Webinar. Future seminars in the Expanding Minds virtual series will be hosted by the Allen Discovery Center for Human Brain Evolution. Visit their website to learn more about the series.
See below for the agenda and speaker information for the Expanding Minds virtual series kick-off to be held on Tuesday, January 26, 2021.

Dr. Rusty Gage: Using Induced Human Neurons and Glia to Model Aging and Age Related Disease
2021-01-26 12:00 - 13:00
President
Professor
Laboratory of Genetics
Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease
Salk Institute
“Using induced human neurons and glia to model aging and age related disease”

+ GOOGLE CALENDAR+ ICAL EXPORT

Details

Date:
January 26
Time:

12:00 pm – 1:00 pm

Event Category:
Seminar

Venue

Zoom

Biostatistics Seminar Series
2021-01-27 12:00 - 13:00
The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings.
This seminar will be held on Zoom due to the COVID-19 pandemic.

Biostatistics Seminar Series:
“The role of mathematical and computational modeling in lung cancer epidemiology and prevention; screening, e-cigarettes and other new challenges 70 years after Doll and Hill”

Seventy years after the seminal smoking and lung cancer work of Doll, Hill, Wynder and Graham, lung cancer remains as the main cause of cancer death globally. While smoking and lung cancer rates are decreasing in the US and screening and treatment improvements provide new tools in the fight against lung cancer, new challenges are arising, including the emergence of e-cigarettes and the continuing disparities in lung cancer outcomes by race and income. Since the 1950s, mathematical modeling has played an important role in advancing our knowledge of lung cancer biology and epidemiology, and in shaping lung cancer prevention and control strategies. In this talk I will describe the contributions of mathematical and computational modeling in cancer epidemiology and prevention, highlighting recent applications in tobacco control and lung cancer prevention, and discussing modeling’s role as we move to a new era of lung cancer research.

Open for (Neuro)Science Tutorials: Tools for Modeling
2021-01-28 10:00 - 11:00
Open for (neuro)science tutorials: Tools for modeling

Date:
Thursday, January 28, 2021
Time:
10:00 AM – 11:00 AM
Location:

Virtual

Join us at this tutorial to learn about modeling tools from the Allen Institute for Brain Science. Learn how and why to use these open resources to support and accelerate your research.

UW Winter Job & Internship Fair
2021-02-02 12:30 - 13:30
Our Fred Hutch and Seattle Cancer Care Alliance recruiting team is meeting (via video/chat) to discuss open full-time, part-time and/or internship opportunities with students and alumni from all UW campuses.
Looking for information on what to expect and how to prepare? Check out the informational page at https://careers.uw.edu/career-fair-faq/

Biostatistics Seminar Series: “Nonparametric Array Learning and its Applications in Neuroimaging”
2021-02-03 12:00 - 13:00
The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings.
This seminar will be held on Zoom due to the COVID-19 pandemic.

Biostatistics Seminar Series:
“Nonparametric array learning and its applications in neuroimaging”

Array-valued predictors ubiquitously arise in brain connectivity studies, sensor network localization, and integrative genomics. We consider the problem of learning the relationship between a scale-valued response and a high-dimensional array-valued predictor. Traditional regression methods take a parametric procedure by imposing a priori functional form between variables. These parametric models, however, are inadequate for structure learning and often fail in accurate prediction. Here, we develop a learning reduction framework to address a range of learning tasks from classification to regression for matrix-valued predictors. Our proposal achieves interpretable prediction via a low-rank two-way sparse halfspace learning for the target function level sets. Statistical accuracy, excess risk bounds, and efficient algorithms are established. We demonstrate the advantage of our method over previous approaches through applications to human brain connectome data. Time allowed, I will present our recent results on nonparametric approaches to tensor estimation and completion.

Date:
Wednesday, February 03, 2021

Start Time:
12 p.m. PST

Host or Sponsor:
Biostatistics Seminar Series

Location:
Zoom Webinar

https://zoom.us/j/95933099692?pwd=[REDACTED]

Speaker or Presenter:
Miaoyan Wang

Contact Information:
shirata@fredhutch.org

Chiari Malformation Webinar
2021-02-03 17:00 - 20:00
Live webinar with physicians about Chiari Malformation

GU Oncology Seminar Series
2021-02-04 17:00 - 18:00
The Genitourinary (GU) Oncology Seminar Series offers a weekly seminar featuring lectures by Fred Hutch, UW, and external scientists to share their latest developments and recent research. This series is hosted jointly by the PNW Prostate SPORE, Program in Prostate Cancer Research (PPCR), and Bladder Cancer Group (BCG).
Livestream: https://us02web.zoom.us/j/85023704247
Feedback form for speaker: https://ppcrspore.formstack.com/forms/ppcr_feedback
View past seminar recordings

Date:
Thursday, February 04, 2021

Start Time:
5 p.m. PST

Host or Sponsor:
Pacific Northwest Prostate Cancer SPORE

Location:
Virtual

Speaker or Presenter:
John Gore, MD, MS, FACS

Contact Information:
PPCR_SPOREadmin@fredhutch.org

Transplantation & Cellular Therapy
2021-02-08 08:00 - 2021-02-12 17:00
Follow Fred Hutch at TCT: #TCTM21

Fred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR).
The meeting features the E. Donnall Thomas Lecture, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation.
Fred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.

CFAR Seminar- The AMP Trials
2021-02-11 16:00 - 17:00
Start Date and Time
February 11, 2021 – 4:00pm

End Date and Time
February 11, 2021 – 5:00pm

Speaker: Lawrence Corey, MD
Past President and Director, Fred Hutch
Professor, Vaccine and Infectious Disease Division, Fred Hutch
Professor, Medicine and Laboratory Medicine, UW
Zoom – washington.zoom.us/j/91567478853
Dr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN)

Dr. Larry Corey is an internationally renowned expert in virology, immunology and vaccine development, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses, HIV, the novel coronavirus and other viral infections, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network, or HVTN, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership, the HVTN has become the model for global, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19.
Dr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences, and was the recipient of the Parran Award for his work in HSV-2, the American Society of Microbiology Cubist Award for his work on antivirals, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author, coauthor or editor of over 1000 scientific publications.

Biostatistics Seminar Series
2021-02-17 12:00 - 13:00
The Fred Hutch Biostatistics Program hosts seminars featuring presentations by Hutch and outside scientists to share their latest developments and recent research. Each seminar includes an hour-long presentation and discussion during which speakers showcase their work and findings.
This seminar will be held on Zoom due to the COVID-19 pandemic.
Lung cancer is one of the most common cancers worldwide and the leading cause of cancer deaths both globally and in the United States. The National Lung Cancer Screening Trial showed annual screening by low-dose computed tomography (LDCT) reduced mortality and in 2013 the US Preventative Services Task Force recommended screening by LDCT for high-risk smokers. A predictive model for 6-year risk of lung cancer was developed using results of the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial (PLCOm2012) and put forth as selection criteria for referral to screening. The Hanash Lab at MD Anderson has established and validated a panel of four circulating protein biomarkers (4MP) for lung cancer risk assessment. In this talk, I will describe joint work with Ziding Feng and the Hanash lab leading to a definitive validation of the 4MP using preclinical specimens from the PLCO biorepository, highlight validation of selection criteria based on combining the 4MP with PLCOm2012, and discuss next steps for investigating the clinical utility of a biomarker-based strategy for referral to LDCT screening.
